Pulmonary circulation-mediated heart targeting for the prevention of heart failure by inhalation of intrinsically bioactive nanoparticles
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (17) , 8550-8569
Abstract
Heart failure is a serious clinical and public health problem. Currently there is an unmet demand for effective therapies for heart failure. Herein we reported noninvasive inhalation delivery of nanotherapies to prevent heart failure.Keywords
This publication has 63 references indexed in Scilit:
- Prolyl Hydroxylase Domain Protein 2 Silencing Enhances the Survival and Paracrine Function of Transplanted Adipose-Derived Stem Cells in Infarcted MyocardiumCirculation Research, 2013
- Heart FailureJACC: Heart Failure, 2013
- Animal Models of Heart FailureCirculation Research, 2012
- Mitochondrial pharmacologyTrends in Pharmacological Sciences, 2012
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategiesJournal of Molecular and Cellular Cardiology, 2012
- Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivoJournal of Controlled Release, 2012
- Therapeutic siRNA silencing in inflammatory monocytes in miceNature Biotechnology, 2011
- Annexin A1 and glucocorticoids as effectors of the resolution of inflammationNature Reviews Immunology, 2009
- Inhaling medicines: delivering drugs to the body through the lungsNature Reviews Drug Discovery, 2007
- Ultrafine Particles Cross Cellular Membranes by Nonphagocytic Mechanisms in Lungs and in Cultured CellsEnvironmental Health Perspectives, 2005